ETFs Novo Nordisk A/S

NOVO B

DK0062498333

Name	Weight	AuM	1st Jan change
XACT NORDEN (UCITS ETF) - SEK	21.31%	201 M€	-1.28%	-
FIRST TRUST IPOX EUROPE EQUITY OPPORTUNITIES ETF - DISTRIBUTING - USD	10.45%	4 M€	+24.38%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	5.4%	21 M€	+4.14%	-
UBS (IRL) ETF PLC MSCI EUROPE ESG UNIVERSAL LOW CARBON SELECT UCITS ETF - ACC - EUR	3.78%	0 M€	-.--%	-
HANETF SATURNA SUSTAINABLE ESG EQUITY HANZERO UCITS ETF - USD	3.41%	0 M€	-.--%	-
AMUNDI INDEX MSCI WORLD SRI PAB - UCITS ETF DR - HEDGED EUR (C)	2.53%	0 M€	-.--%	-
AMUNDI INDEX MSCI WORLD SRI PAB - UCITS ETF DR (C) - EUR	2.53%	0 M€	-.--%	-
FRANKLIN LIBERTYQ EUROPEAN EQUITY UCITS ETF - EUR	2.22%	0 M€	-.--%	-
CSIF (IE) MSCI WORLD ESG LEADERS MINIMUM VOLATILITY BLUE UCITS ETF B - USD	1.31%	0 M€	-.--%	-
DEMOCRACY INTERNATIONAL FUND ETF - USD	1.03%	9 M€	+15.41%	-
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF	1.02%	33,076 M€	+11.29%	-
HARTFORD MULTIFACTOR DEVELOPED MARKETS (EX-US) ETF - USD	0.89%	1,022 M€	+20.44%	-
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD	0.79%	0 M€	-.--%	-
AMUNDI MSCI WORLD CLIMATE TRANSITION CTB - UCITS ETF DR (C) - USD	0.76%	0 M€	-.--%	-
LYXOR MSCI WORLD CLIMATE CHANGE (DR) UCITS ETF - ACC - USD	0.75%	0 M€	-.--%	-
VANECK SUSTAINABLE WORLD EQUAL WEIGHT UCITS ETF - EUR	0.57%	908 M€	+1.85%	-
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR	0.56%	0 M€	-.--%	-
AMUNDI INDEX MSCI WORLD - UCITS ETF DR (C) - EUR	0.56%	0 M€	-.--%	-

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.6%); - rare disease treatment products (6.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (20.8%), the United States (57.6%), North America (3.7%), China (6.4%) and other (11.5%).

Employees

77,406

Sector

Pharmaceuticals

Calendar

08-06 - Q2 2025 Earnings Release

More about the company

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG MSCI

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

443.05DKK

Average target price

644.77DKK

Spread / Average Target

+45.53%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Real-time Estimate Cboe Europe Other stock markets 11:38:18 10/07/2025 BST			5-day change	1st Jan Change
445.20 ^DKK	+0.49%		+1.85%	-28.55%

07-09	Major deals involving U.S. drugmakers and biotechs over the past decade	RE
07-09	European shares close at four-week high on banks boost; US trade talks in focus	RE